The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. Authors marked with an asterisk (*) are participants in ASCO’s Disclosure Management System Pilot; their disclosure is not limited to subject matter under consideration in this article and includes payments to themselves, an immediate family member (I), and/or their institutions (Inst). For information on the pilot program, or to provide feedback, please visit coipilot.asco.org. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Stanford V chemotherapy and involved field radiotherapy for children and adolescents with unfavorable risk Hodgkin lymphoma: Results of a multi-institutional prospective clinical trial.
Monika Metzger
Research Funding - AstraZeneca; Pfizer
Amy Billett
No relevant relationships to disclose
Alison M. Friedmann
No relevant relationships to disclose
Matthew J. Krasin
No relevant relationships to disclose
Scott C. Howard
No relevant relationships to disclose
Howard J. Weinstein
No relevant relationships to disclose
Eric Larsen
No relevant relationships to disclose
Karen Chayt Marcus
No relevant relationships to disclose
Catherine Billups
No relevant relationships to disclose
Jianrong Wu
No relevant relationships to disclose
Sarah S. Donaldson
Disclosure not yet available
* Michael Paul Link
Disclosure not yet available
Melissa M. Hudson
Disclosure not yet available